Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 05, 2012 16:05 ET | Source: Idenix Pharmaceuticals

Idenix Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare Conference

CAMBRIDGE, Mass., Dec. 5, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present a corporate overview at the Oppenheimer 23rd Annual...
November 26, 2012 16:05 ET | Source: Idenix Pharmaceuticals

Idenix Pharmaceuticals to Present at the 2012 Deutsche Bank Access BioFEST Conference

CAMBRIDGE, Mass., Nov. 26, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present in a fireside chat at the 2012 Deutsche Bank Access...
November 10, 2012 09:05 ET | Source: Idenix Pharmaceuticals

Idenix Pharmaceuticals Reports Clinical Data for HCV Drug Candidates - IDX719 and IDX184 - at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting

CAMBRIDGE, Mass., Nov. 10, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
November 01, 2012 16:05 ET | Source: Idenix Pharmaceuticals

Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2012 Financial Results and HCV Program Update

CAMBRIDGE, Mass., Nov. 1, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
October 25, 2012 16:05 ET | Source: Idenix Pharmaceuticals

Idenix to Host Conference Call Discussing Third Quarter and Nine Month 2012 Financial Results and HCV Program Update

CAMBRIDGE, Mass., Oct. 25, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc., (Nasdaq:IDIX) announced today that it will report its financial results for the third quarter of 2012 on Thursday,...
September 13, 2012 16:05 ET | Source: Idenix Pharmaceuticals

Idenix Pharmaceuticals to Present at the UBS Global Life Sciences Conference

CAMBRIDGE, Mass., Sept. 13, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present a corporate overview at the UBS Global Life Sciences...
August 29, 2012 16:05 ET | Source: Idenix Pharmaceuticals

Idenix Pharmaceuticals to Present at Three Upcoming Investor Conferences

CAMBRIDGE, Mass., Aug. 29, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), announced today that Idenix management will participate in a panel discussion at Citigroup's 7th Annual...
August 27, 2012 08:30 ET | Source: Idenix Pharmaceuticals

Idenix Provides Update on IDX19368 Development Program

CAMBRIDGE, Mass., Aug. 27, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
August 16, 2012 08:00 ET | Source: Idenix Pharmaceuticals

Idenix Provides Update on IDX184 Clinical Development Program

IDX184 has been placed on partial clinical hold by FDA Management to host a conference call webcast today at 8:30 am ET CAMBRIDGE, Mass., Aug. 16, 2012 (GLOBE NEWSWIRE) -- Idenix...
August 09, 2012 08:30 ET | Source: Idenix Pharmaceuticals

Idenix Pharmaceuticals to Present at the 2012 Wedbush PacGrow Lifesciences Management Access Conference

CAMBRIDGE, Mass., Aug. 9, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present a corporate overview at the 2012 Wedbush PacGrow...